SHL Telemedicine reports second quarter and half year 2012 results
- Revenues for the quarter of USD 6.6 million
- EBITDA for the quarter of USD 0.4 million
- LBIT for the quarter of USD 0.6 million
- Net loss for the quarter of USD 0.9 million
- Positive operating cash flow
- Recruiting new patients in Germany
Tel Aviv/Zurich, 30 August 2012 – SHL Telemedicine Ltd. (SIX Swiss Exchange:
SHLTN), a leading provider and developer of advanced personal telemedicine solutions,
today announced results for the second quarter of 2012.
Erez Alroy, Co-CEO of SHL, commented: “The half-year results reflect the transition
period we have communicated earlier this year. We are recruiting patients for the major
contract we signed with IKK Südwest in Germany in the first quarter, the effect to
become visible over the next quarters.” And he added: “The multi-year tender with AOK
BAYERN, a milestone in SHL’s history, for the provision to insured with Chronic
Obstructive Pulmonary Disease (COPD), which we won in May, will enable us to scale
up our German operations. The agreement is expected to close this quarter.”
